/
CATX
$3.10-$0.16 (-4.91%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$372.1M
114M shares
52-week range
$1.96 – $6.16
27% from low
Sector
PHARMACEUTICAL PREPARATIONS
Exchange
XASE
CS
Change$-0.70
Perspective Therapeutics, Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.
www.perspectivetherapeutics.com- Employees
- 166
- IPO / List date
- Dec 29, 2003
- HQ
- SEATTLE, WA
Held by traders on TradeandTell
No one on the platform currently holds CATX.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2025-12-31 | 352,493 | $969.4K |
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2024-06-17 | 1-for-10reverse |
Recent trades on TradeandTell
No one on the platform has traded CATX yet.
